Xerafy is set to highlight its advanced RAIN RFID labeling solutions targeted at the pharmaceutical and healthcare sectors during the AIPIA Innovation Stage at CPHI South East Asia 2026. This significant event will be held in Bangkok, Thailand, from July 8 to 10. The focus will be on RFID technology applications that enhance packaging in pharmaceuticals, ensure traceability for medical devices, and optimize inventory management and supply chain transparency in healthcare.
Among the innovative products that Xerafy will showcase are the XSKIN Gamma, which is suitable for gamma-sterilized packaging, the MICRO Medical, designed for identifying compact medical devices, and the Metal Skin Delta, tailored for assets in healthcare environments and metallized packaging. These solutions illustrate how RFID labels can revolutionize the pharmaceutical supply chains by delivering item-level identification and facilitating real-time data acquisition throughout various stages, including manufacturing, sterilization, warehousing, distribution, and healthcare operations.
The deployment of smart RAIN RFID labels is becoming increasingly vital as pharmaceutical supply chains grow more intricate. These technologies enhance product traceability, improve inventory accuracy, and ensure compliance by integrating physical products with their digital records. Xerafy emphasizes that its RFID solutions are engineered to perform in rigorous environments where traditional barcode systems might fall short, especially in scenarios involving bulk handling, dense storage, and regulated healthcare applications.
Xerafy’s array of RFID labels and tags is specifically designed to cater to demanding sectors such as healthcare, manufacturing, logistics, aerospace, oil and gas, and data centers. These labels and tags offer tailored solutions to meet the unique needs of each industry, ensuring efficiency and compliance. The company’s presentation at the CPHI South East Asia 2026 will demonstrate the potential of connected packaging and RFID technology to streamline and enhance the efficiency of pharmaceutical and medical device supply chains.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.